Evidence map›Paper›PMID 40612768›Full record

ArticleFood chemistry: X2025

Epigallocatechin gallate-mediated interaction modulates the gelation properties and antibacterial spectrum of rigid amyloid lysozyme fibril-chitosan hydrogels.

Hui Huang, Fang Wang, Xili Xiao, Qun Huang, Jing Wang, Yifeng Shen, Na Gao

Abstract read
In one paragraph

Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui HuangDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.
Fang WangDepartment of Ophthalmology, Chengdu First People's Hospital, 18 North Wanxiang Road, High-tech Zone, Chengdu City 610499, China.
Xili XiaoDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.
Qun HuangDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.
Jing WangDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.
Yifeng ShenTCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.
Na GaoDepartment of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, 39 Shierqiao Road, Jinniu District, Chengdu 610032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study systematically investigated the molecular interactions underlying the construction of an epigallocatechin gallate (EGCG)-mediated lysozyme amyloid fibrils (LAFs)-chitosan hydrogel. The multiple hydroxyl and aromatic ring structures of EGCG were found to interact with LAFs, resulting in a redistribution of the surface charge of the complex. Meanwhile, the exposure of EGCG's hydrophilic intervals facilitated stronger interactions with the aromatic amino acids of LAFs, leading to a conformation change of LAFs from β-Sheet to β-turn. The incorporation of EGCG-LAFs enhanced the network strength of chitosan hydrogels, forming a characteristic meso-network of amyloid fibers, evidenced by a significant increase in gel hardness, reaching a peak value of 2176.71 g. The EGCG-LAFs-chitosan composite hydrogel exhibited excellent antibacterial activity against

Indexed as

Anti-microbialChitosanEpigallocatechin gallateGelInteraction forceLysozyme

Identifiers

PMID40612768
PMCPMC12226057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.